Global Peptides

Peptides Comprehensive Study by Type (Custom (Standard , Quant , Cyclic Custom , Others), Catalog (Neuroscience, Cardiovascular, Diabetes, Others)), Application (Commercial, Academic Research, Therapeutics), Natural Peptides (Insulin, Endorphins, Somatropin) Players and Region - Global Market Outlook to 2028

Peptides Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Peptides are naturally occurring biological molecules, found in all living organisms and play a major role in biological activity. Synthesized forms of peptides are formed naturally from the transcription of a sequence of the genetic code, DNA. Peptides are found in every cell and tissue and perform a wide range of essential functions. To achieve good homeostasis it is very important to maintain the appropriate concentration of peptides. The major function of peptides is dependent on the types of amino acids involved in the chain and their sequence. Peptide medicines are effectively used to replace or mimic the functions of naturally occurring peptides or to imitate the ability of peptides to engage targets in a highly potent and selective manner. Few peptide therapies are made by using chemical processes, while the rest are produced inside genetically modified cells.

AttributesDetails
Study Period2018-2028
Base Year2022
High Growth MarketAsia Pacific
Current Value (2022)USD 505.0 Million
UnitValue (USD Million)
Key Companies ProfiledZealand Pharma A/S (Denmark), Tocris Bioscience (England), AnaSpec, Inc. (United States), CSBio (United States), GL Biochem (Shanghai) Ltd. (China), CPC Scientific Inc. (United States), Auspep Pty Ltd. (Australia), Peptides International Inc. (United States), Applied Biological Materials (ABM) Inc. (Canada), Thermo Fisher Scientific (United States) and PolyPeptide Group (Sweden)


This growth is primarily driven by Growing Demand for Research and Development Protein-Based Activities and Increase Burden of Chronic Diseases.

Globally, a noticeable market trend is evident Development in Manufacturing Technologies of Peptides The Biotechnology sector in the North America region has been increasing at a sustainable rate, and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Zealand Pharma A/S (Denmark), Tocris Bioscience (England), AnaSpec, Inc. (United States), CSBio (United States), GL Biochem (Shanghai) Ltd. (China), CPC Scientific Inc. (United States), Auspep Pty Ltd. (Australia), Peptides International Inc. (United States), Applied Biological Materials (ABM) Inc. (Canada), Thermo Fisher Scientific (United States) and PolyPeptide Group (Sweden), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years. The global peptides market is highly competitive and consists of some key players. In terms of market share, few of the key players presently dominate the global market. These market players are leveraging on strategic collaborative creativities to intensify their market share and escalation their profitability.

Key Developments in the Market:
In March 2019, Alexion Pharmaceuticals and Zealand Pharma announced the collaboration to discover and develop novel peptide therapies for mediated diseases. Through this collaboration, Alexion gets exclusive worldwide license, development, and commercial rights within the complement pathways.
In Mar 2019, Creative Peptides announced the launch of its new pharmaceutical peptides services and the extension of the application of peptides into pharmaceutical research and drug development.

Influencing Trend:
Development in Manufacturing Technologies of Peptides and High Demand for Catalog Peptides in Commercial Applications

Market Growth Drivers:
Growing Demand for Research and Development Protein-Based Activities and Increase Burden of Chronic Diseases

Challenges:
Stringent Regulations in Various Regions

Restraints:
High Cost of Manufacturing Process, High Contamination Issues While Peptides Synthesis and Growing Requirement of Drug Development and Rapid Development in Drug Production Technologies

Opportunities:
Advancement in Research and Development Industry and Growing Number of Pharmaceutical and Biotechnology Companies in Asia Pacific Regions

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Peptides Market
- Analysis about New Entrants in Peptides Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators

Against this Challenging Backdrop, Peptides Study Sheds Light on
— The Peptides Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Peptides industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Peptides industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Custom (Standard , Quant , Cyclic Custom , Others)
  • Catalog (Neuroscience, Cardiovascular, Diabetes, Others)
By Application
  • Commercial
  • Academic Research
  • Therapeutics
By Natural Peptides
  • Insulin
  • Endorphins
  • Somatropin

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Demand for Research and Development Protein-Based Activities
      • 3.2.2. Increase Burden of Chronic Diseases
    • 3.3. Market Challenges
      • 3.3.1. Stringent Regulations in Various Regions
    • 3.4. Market Trends
      • 3.4.1. Development in Manufacturing Technologies of Peptides
      • 3.4.2. High Demand for Catalog Peptides in Commercial Applications
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Peptides, by Type, Application, Natural Peptides and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Peptides (Value)
      • 5.2.1. Global Peptides by: Type (Value)
        • 5.2.1.1. Custom (Standard , Quant , Cyclic Custom , Others)
        • 5.2.1.2. Catalog (Neuroscience, Cardiovascular, Diabetes, Others)
      • 5.2.2. Global Peptides by: Application (Value)
        • 5.2.2.1. Commercial
        • 5.2.2.2. Academic Research
        • 5.2.2.3. Therapeutics
      • 5.2.3. Global Peptides by: Natural Peptides (Value)
        • 5.2.3.1. Insulin
        • 5.2.3.2. Endorphins
        • 5.2.3.3. Somatropin
      • 5.2.4. Global Peptides Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Peptides (Volume)
      • 5.3.1. Global Peptides by: Type (Volume)
        • 5.3.1.1. Custom (Standard , Quant , Cyclic Custom , Others)
        • 5.3.1.2. Catalog (Neuroscience, Cardiovascular, Diabetes, Others)
      • 5.3.2. Global Peptides by: Application (Volume)
        • 5.3.2.1. Commercial
        • 5.3.2.2. Academic Research
        • 5.3.2.3. Therapeutics
      • 5.3.3. Global Peptides by: Natural Peptides (Volume)
        • 5.3.3.1. Insulin
        • 5.3.3.2. Endorphins
        • 5.3.3.3. Somatropin
      • 5.3.4. Global Peptides Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Peptides (Price)
      • 5.4.1. Global Peptides by: Type (Price)
  • 6. Peptides: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Zealand Pharma A/S (Denmark)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Tocris Bioscience (England)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. AnaSpec, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. CSBio (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. GL Biochem (Shanghai) Ltd. (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. CPC Scientific Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Auspep Pty Ltd. (Australia)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Peptides International Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Applied Biological Materials (ABM) Inc. (Canada)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Thermo Fisher Scientific (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. PolyPeptide Group (Sweden)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Peptides Sale, by Type, Application, Natural Peptides and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Peptides (Value)
      • 7.2.1. Global Peptides by: Type (Value)
        • 7.2.1.1. Custom (Standard , Quant , Cyclic Custom , Others)
        • 7.2.1.2. Catalog (Neuroscience, Cardiovascular, Diabetes, Others)
      • 7.2.2. Global Peptides by: Application (Value)
        • 7.2.2.1. Commercial
        • 7.2.2.2. Academic Research
        • 7.2.2.3. Therapeutics
      • 7.2.3. Global Peptides by: Natural Peptides (Value)
        • 7.2.3.1. Insulin
        • 7.2.3.2. Endorphins
        • 7.2.3.3. Somatropin
      • 7.2.4. Global Peptides Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Peptides (Volume)
      • 7.3.1. Global Peptides by: Type (Volume)
        • 7.3.1.1. Custom (Standard , Quant , Cyclic Custom , Others)
        • 7.3.1.2. Catalog (Neuroscience, Cardiovascular, Diabetes, Others)
      • 7.3.2. Global Peptides by: Application (Volume)
        • 7.3.2.1. Commercial
        • 7.3.2.2. Academic Research
        • 7.3.2.3. Therapeutics
      • 7.3.3. Global Peptides by: Natural Peptides (Volume)
        • 7.3.3.1. Insulin
        • 7.3.3.2. Endorphins
        • 7.3.3.3. Somatropin
      • 7.3.4. Global Peptides Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Peptides (Price)
      • 7.4.1. Global Peptides by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Peptides: by Type(USD Million)
  • Table 2. Peptides Custom (Standard , Quant , Cyclic Custom , Others) , by Region USD Million (2017-2022)
  • Table 3. Peptides Catalog (Neuroscience, Cardiovascular, Diabetes, Others) , by Region USD Million (2017-2022)
  • Table 4. Peptides: by Application(USD Million)
  • Table 5. Peptides Commercial , by Region USD Million (2017-2022)
  • Table 6. Peptides Academic Research , by Region USD Million (2017-2022)
  • Table 7. Peptides Therapeutics , by Region USD Million (2017-2022)
  • Table 8. Peptides: by Natural Peptides(USD Million)
  • Table 9. Peptides Insulin , by Region USD Million (2017-2022)
  • Table 10. Peptides Endorphins , by Region USD Million (2017-2022)
  • Table 11. Peptides Somatropin , by Region USD Million (2017-2022)
  • Table 12. South America Peptides, by Country USD Million (2017-2022)
  • Table 13. South America Peptides, by Type USD Million (2017-2022)
  • Table 14. South America Peptides, by Application USD Million (2017-2022)
  • Table 15. South America Peptides, by Natural Peptides USD Million (2017-2022)
  • Table 16. Brazil Peptides, by Type USD Million (2017-2022)
  • Table 17. Brazil Peptides, by Application USD Million (2017-2022)
  • Table 18. Brazil Peptides, by Natural Peptides USD Million (2017-2022)
  • Table 19. Argentina Peptides, by Type USD Million (2017-2022)
  • Table 20. Argentina Peptides, by Application USD Million (2017-2022)
  • Table 21. Argentina Peptides, by Natural Peptides USD Million (2017-2022)
  • Table 22. Rest of South America Peptides, by Type USD Million (2017-2022)
  • Table 23. Rest of South America Peptides, by Application USD Million (2017-2022)
  • Table 24. Rest of South America Peptides, by Natural Peptides USD Million (2017-2022)
  • Table 25. Asia Pacific Peptides, by Country USD Million (2017-2022)
  • Table 26. Asia Pacific Peptides, by Type USD Million (2017-2022)
  • Table 27. Asia Pacific Peptides, by Application USD Million (2017-2022)
  • Table 28. Asia Pacific Peptides, by Natural Peptides USD Million (2017-2022)
  • Table 29. China Peptides, by Type USD Million (2017-2022)
  • Table 30. China Peptides, by Application USD Million (2017-2022)
  • Table 31. China Peptides, by Natural Peptides USD Million (2017-2022)
  • Table 32. Japan Peptides, by Type USD Million (2017-2022)
  • Table 33. Japan Peptides, by Application USD Million (2017-2022)
  • Table 34. Japan Peptides, by Natural Peptides USD Million (2017-2022)
  • Table 35. India Peptides, by Type USD Million (2017-2022)
  • Table 36. India Peptides, by Application USD Million (2017-2022)
  • Table 37. India Peptides, by Natural Peptides USD Million (2017-2022)
  • Table 38. South Korea Peptides, by Type USD Million (2017-2022)
  • Table 39. South Korea Peptides, by Application USD Million (2017-2022)
  • Table 40. South Korea Peptides, by Natural Peptides USD Million (2017-2022)
  • Table 41. Taiwan Peptides, by Type USD Million (2017-2022)
  • Table 42. Taiwan Peptides, by Application USD Million (2017-2022)
  • Table 43. Taiwan Peptides, by Natural Peptides USD Million (2017-2022)
  • Table 44. Australia Peptides, by Type USD Million (2017-2022)
  • Table 45. Australia Peptides, by Application USD Million (2017-2022)
  • Table 46. Australia Peptides, by Natural Peptides USD Million (2017-2022)
  • Table 47. Rest of Asia-Pacific Peptides, by Type USD Million (2017-2022)
  • Table 48. Rest of Asia-Pacific Peptides, by Application USD Million (2017-2022)
  • Table 49. Rest of Asia-Pacific Peptides, by Natural Peptides USD Million (2017-2022)
  • Table 50. Europe Peptides, by Country USD Million (2017-2022)
  • Table 51. Europe Peptides, by Type USD Million (2017-2022)
  • Table 52. Europe Peptides, by Application USD Million (2017-2022)
  • Table 53. Europe Peptides, by Natural Peptides USD Million (2017-2022)
  • Table 54. Germany Peptides, by Type USD Million (2017-2022)
  • Table 55. Germany Peptides, by Application USD Million (2017-2022)
  • Table 56. Germany Peptides, by Natural Peptides USD Million (2017-2022)
  • Table 57. France Peptides, by Type USD Million (2017-2022)
  • Table 58. France Peptides, by Application USD Million (2017-2022)
  • Table 59. France Peptides, by Natural Peptides USD Million (2017-2022)
  • Table 60. Italy Peptides, by Type USD Million (2017-2022)
  • Table 61. Italy Peptides, by Application USD Million (2017-2022)
  • Table 62. Italy Peptides, by Natural Peptides USD Million (2017-2022)
  • Table 63. United Kingdom Peptides, by Type USD Million (2017-2022)
  • Table 64. United Kingdom Peptides, by Application USD Million (2017-2022)
  • Table 65. United Kingdom Peptides, by Natural Peptides USD Million (2017-2022)
  • Table 66. Netherlands Peptides, by Type USD Million (2017-2022)
  • Table 67. Netherlands Peptides, by Application USD Million (2017-2022)
  • Table 68. Netherlands Peptides, by Natural Peptides USD Million (2017-2022)
  • Table 69. Rest of Europe Peptides, by Type USD Million (2017-2022)
  • Table 70. Rest of Europe Peptides, by Application USD Million (2017-2022)
  • Table 71. Rest of Europe Peptides, by Natural Peptides USD Million (2017-2022)
  • Table 72. MEA Peptides, by Country USD Million (2017-2022)
  • Table 73. MEA Peptides, by Type USD Million (2017-2022)
  • Table 74. MEA Peptides, by Application USD Million (2017-2022)
  • Table 75. MEA Peptides, by Natural Peptides USD Million (2017-2022)
  • Table 76. Middle East Peptides, by Type USD Million (2017-2022)
  • Table 77. Middle East Peptides, by Application USD Million (2017-2022)
  • Table 78. Middle East Peptides, by Natural Peptides USD Million (2017-2022)
  • Table 79. Africa Peptides, by Type USD Million (2017-2022)
  • Table 80. Africa Peptides, by Application USD Million (2017-2022)
  • Table 81. Africa Peptides, by Natural Peptides USD Million (2017-2022)
  • Table 82. North America Peptides, by Country USD Million (2017-2022)
  • Table 83. North America Peptides, by Type USD Million (2017-2022)
  • Table 84. North America Peptides, by Application USD Million (2017-2022)
  • Table 85. North America Peptides, by Natural Peptides USD Million (2017-2022)
  • Table 86. United States Peptides, by Type USD Million (2017-2022)
  • Table 87. United States Peptides, by Application USD Million (2017-2022)
  • Table 88. United States Peptides, by Natural Peptides USD Million (2017-2022)
  • Table 89. Canada Peptides, by Type USD Million (2017-2022)
  • Table 90. Canada Peptides, by Application USD Million (2017-2022)
  • Table 91. Canada Peptides, by Natural Peptides USD Million (2017-2022)
  • Table 92. Mexico Peptides, by Type USD Million (2017-2022)
  • Table 93. Mexico Peptides, by Application USD Million (2017-2022)
  • Table 94. Mexico Peptides, by Natural Peptides USD Million (2017-2022)
  • Table 95. Peptides Sales: by Type(K Units)
  • Table 96. Peptides Sales Custom (Standard , Quant , Cyclic Custom , Others) , by Region K Units (2017-2022)
  • Table 97. Peptides Sales Catalog (Neuroscience, Cardiovascular, Diabetes, Others) , by Region K Units (2017-2022)
  • Table 98. Peptides Sales: by Application(K Units)
  • Table 99. Peptides Sales Commercial , by Region K Units (2017-2022)
  • Table 100. Peptides Sales Academic Research , by Region K Units (2017-2022)
  • Table 101. Peptides Sales Therapeutics , by Region K Units (2017-2022)
  • Table 102. Peptides Sales: by Natural Peptides(K Units)
  • Table 103. Peptides Sales Insulin , by Region K Units (2017-2022)
  • Table 104. Peptides Sales Endorphins , by Region K Units (2017-2022)
  • Table 105. Peptides Sales Somatropin , by Region K Units (2017-2022)
  • Table 106. South America Peptides Sales, by Country K Units (2017-2022)
  • Table 107. South America Peptides Sales, by Type K Units (2017-2022)
  • Table 108. South America Peptides Sales, by Application K Units (2017-2022)
  • Table 109. South America Peptides Sales, by Natural Peptides K Units (2017-2022)
  • Table 110. Brazil Peptides Sales, by Type K Units (2017-2022)
  • Table 111. Brazil Peptides Sales, by Application K Units (2017-2022)
  • Table 112. Brazil Peptides Sales, by Natural Peptides K Units (2017-2022)
  • Table 113. Argentina Peptides Sales, by Type K Units (2017-2022)
  • Table 114. Argentina Peptides Sales, by Application K Units (2017-2022)
  • Table 115. Argentina Peptides Sales, by Natural Peptides K Units (2017-2022)
  • Table 116. Rest of South America Peptides Sales, by Type K Units (2017-2022)
  • Table 117. Rest of South America Peptides Sales, by Application K Units (2017-2022)
  • Table 118. Rest of South America Peptides Sales, by Natural Peptides K Units (2017-2022)
  • Table 119. Asia Pacific Peptides Sales, by Country K Units (2017-2022)
  • Table 120. Asia Pacific Peptides Sales, by Type K Units (2017-2022)
  • Table 121. Asia Pacific Peptides Sales, by Application K Units (2017-2022)
  • Table 122. Asia Pacific Peptides Sales, by Natural Peptides K Units (2017-2022)
  • Table 123. China Peptides Sales, by Type K Units (2017-2022)
  • Table 124. China Peptides Sales, by Application K Units (2017-2022)
  • Table 125. China Peptides Sales, by Natural Peptides K Units (2017-2022)
  • Table 126. Japan Peptides Sales, by Type K Units (2017-2022)
  • Table 127. Japan Peptides Sales, by Application K Units (2017-2022)
  • Table 128. Japan Peptides Sales, by Natural Peptides K Units (2017-2022)
  • Table 129. India Peptides Sales, by Type K Units (2017-2022)
  • Table 130. India Peptides Sales, by Application K Units (2017-2022)
  • Table 131. India Peptides Sales, by Natural Peptides K Units (2017-2022)
  • Table 132. South Korea Peptides Sales, by Type K Units (2017-2022)
  • Table 133. South Korea Peptides Sales, by Application K Units (2017-2022)
  • Table 134. South Korea Peptides Sales, by Natural Peptides K Units (2017-2022)
  • Table 135. Taiwan Peptides Sales, by Type K Units (2017-2022)
  • Table 136. Taiwan Peptides Sales, by Application K Units (2017-2022)
  • Table 137. Taiwan Peptides Sales, by Natural Peptides K Units (2017-2022)
  • Table 138. Australia Peptides Sales, by Type K Units (2017-2022)
  • Table 139. Australia Peptides Sales, by Application K Units (2017-2022)
  • Table 140. Australia Peptides Sales, by Natural Peptides K Units (2017-2022)
  • Table 141. Rest of Asia-Pacific Peptides Sales, by Type K Units (2017-2022)
  • Table 142. Rest of Asia-Pacific Peptides Sales, by Application K Units (2017-2022)
  • Table 143. Rest of Asia-Pacific Peptides Sales, by Natural Peptides K Units (2017-2022)
  • Table 144. Europe Peptides Sales, by Country K Units (2017-2022)
  • Table 145. Europe Peptides Sales, by Type K Units (2017-2022)
  • Table 146. Europe Peptides Sales, by Application K Units (2017-2022)
  • Table 147. Europe Peptides Sales, by Natural Peptides K Units (2017-2022)
  • Table 148. Germany Peptides Sales, by Type K Units (2017-2022)
  • Table 149. Germany Peptides Sales, by Application K Units (2017-2022)
  • Table 150. Germany Peptides Sales, by Natural Peptides K Units (2017-2022)
  • Table 151. France Peptides Sales, by Type K Units (2017-2022)
  • Table 152. France Peptides Sales, by Application K Units (2017-2022)
  • Table 153. France Peptides Sales, by Natural Peptides K Units (2017-2022)
  • Table 154. Italy Peptides Sales, by Type K Units (2017-2022)
  • Table 155. Italy Peptides Sales, by Application K Units (2017-2022)
  • Table 156. Italy Peptides Sales, by Natural Peptides K Units (2017-2022)
  • Table 157. United Kingdom Peptides Sales, by Type K Units (2017-2022)
  • Table 158. United Kingdom Peptides Sales, by Application K Units (2017-2022)
  • Table 159. United Kingdom Peptides Sales, by Natural Peptides K Units (2017-2022)
  • Table 160. Netherlands Peptides Sales, by Type K Units (2017-2022)
  • Table 161. Netherlands Peptides Sales, by Application K Units (2017-2022)
  • Table 162. Netherlands Peptides Sales, by Natural Peptides K Units (2017-2022)
  • Table 163. Rest of Europe Peptides Sales, by Type K Units (2017-2022)
  • Table 164. Rest of Europe Peptides Sales, by Application K Units (2017-2022)
  • Table 165. Rest of Europe Peptides Sales, by Natural Peptides K Units (2017-2022)
  • Table 166. MEA Peptides Sales, by Country K Units (2017-2022)
  • Table 167. MEA Peptides Sales, by Type K Units (2017-2022)
  • Table 168. MEA Peptides Sales, by Application K Units (2017-2022)
  • Table 169. MEA Peptides Sales, by Natural Peptides K Units (2017-2022)
  • Table 170. Middle East Peptides Sales, by Type K Units (2017-2022)
  • Table 171. Middle East Peptides Sales, by Application K Units (2017-2022)
  • Table 172. Middle East Peptides Sales, by Natural Peptides K Units (2017-2022)
  • Table 173. Africa Peptides Sales, by Type K Units (2017-2022)
  • Table 174. Africa Peptides Sales, by Application K Units (2017-2022)
  • Table 175. Africa Peptides Sales, by Natural Peptides K Units (2017-2022)
  • Table 176. North America Peptides Sales, by Country K Units (2017-2022)
  • Table 177. North America Peptides Sales, by Type K Units (2017-2022)
  • Table 178. North America Peptides Sales, by Application K Units (2017-2022)
  • Table 179. North America Peptides Sales, by Natural Peptides K Units (2017-2022)
  • Table 180. United States Peptides Sales, by Type K Units (2017-2022)
  • Table 181. United States Peptides Sales, by Application K Units (2017-2022)
  • Table 182. United States Peptides Sales, by Natural Peptides K Units (2017-2022)
  • Table 183. Canada Peptides Sales, by Type K Units (2017-2022)
  • Table 184. Canada Peptides Sales, by Application K Units (2017-2022)
  • Table 185. Canada Peptides Sales, by Natural Peptides K Units (2017-2022)
  • Table 186. Mexico Peptides Sales, by Type K Units (2017-2022)
  • Table 187. Mexico Peptides Sales, by Application K Units (2017-2022)
  • Table 188. Mexico Peptides Sales, by Natural Peptides K Units (2017-2022)
  • Table 189. Peptides: by Type(USD/Units)
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Company Basic Information, Sales Area and Its Competitors
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Peptides: by Type(USD Million)
  • Table 202. Peptides Custom (Standard , Quant , Cyclic Custom , Others) , by Region USD Million (2023-2028)
  • Table 203. Peptides Catalog (Neuroscience, Cardiovascular, Diabetes, Others) , by Region USD Million (2023-2028)
  • Table 204. Peptides: by Application(USD Million)
  • Table 205. Peptides Commercial , by Region USD Million (2023-2028)
  • Table 206. Peptides Academic Research , by Region USD Million (2023-2028)
  • Table 207. Peptides Therapeutics , by Region USD Million (2023-2028)
  • Table 208. Peptides: by Natural Peptides(USD Million)
  • Table 209. Peptides Insulin , by Region USD Million (2023-2028)
  • Table 210. Peptides Endorphins , by Region USD Million (2023-2028)
  • Table 211. Peptides Somatropin , by Region USD Million (2023-2028)
  • Table 212. South America Peptides, by Country USD Million (2023-2028)
  • Table 213. South America Peptides, by Type USD Million (2023-2028)
  • Table 214. South America Peptides, by Application USD Million (2023-2028)
  • Table 215. South America Peptides, by Natural Peptides USD Million (2023-2028)
  • Table 216. Brazil Peptides, by Type USD Million (2023-2028)
  • Table 217. Brazil Peptides, by Application USD Million (2023-2028)
  • Table 218. Brazil Peptides, by Natural Peptides USD Million (2023-2028)
  • Table 219. Argentina Peptides, by Type USD Million (2023-2028)
  • Table 220. Argentina Peptides, by Application USD Million (2023-2028)
  • Table 221. Argentina Peptides, by Natural Peptides USD Million (2023-2028)
  • Table 222. Rest of South America Peptides, by Type USD Million (2023-2028)
  • Table 223. Rest of South America Peptides, by Application USD Million (2023-2028)
  • Table 224. Rest of South America Peptides, by Natural Peptides USD Million (2023-2028)
  • Table 225. Asia Pacific Peptides, by Country USD Million (2023-2028)
  • Table 226. Asia Pacific Peptides, by Type USD Million (2023-2028)
  • Table 227. Asia Pacific Peptides, by Application USD Million (2023-2028)
  • Table 228. Asia Pacific Peptides, by Natural Peptides USD Million (2023-2028)
  • Table 229. China Peptides, by Type USD Million (2023-2028)
  • Table 230. China Peptides, by Application USD Million (2023-2028)
  • Table 231. China Peptides, by Natural Peptides USD Million (2023-2028)
  • Table 232. Japan Peptides, by Type USD Million (2023-2028)
  • Table 233. Japan Peptides, by Application USD Million (2023-2028)
  • Table 234. Japan Peptides, by Natural Peptides USD Million (2023-2028)
  • Table 235. India Peptides, by Type USD Million (2023-2028)
  • Table 236. India Peptides, by Application USD Million (2023-2028)
  • Table 237. India Peptides, by Natural Peptides USD Million (2023-2028)
  • Table 238. South Korea Peptides, by Type USD Million (2023-2028)
  • Table 239. South Korea Peptides, by Application USD Million (2023-2028)
  • Table 240. South Korea Peptides, by Natural Peptides USD Million (2023-2028)
  • Table 241. Taiwan Peptides, by Type USD Million (2023-2028)
  • Table 242. Taiwan Peptides, by Application USD Million (2023-2028)
  • Table 243. Taiwan Peptides, by Natural Peptides USD Million (2023-2028)
  • Table 244. Australia Peptides, by Type USD Million (2023-2028)
  • Table 245. Australia Peptides, by Application USD Million (2023-2028)
  • Table 246. Australia Peptides, by Natural Peptides USD Million (2023-2028)
  • Table 247. Rest of Asia-Pacific Peptides, by Type USD Million (2023-2028)
  • Table 248. Rest of Asia-Pacific Peptides, by Application USD Million (2023-2028)
  • Table 249. Rest of Asia-Pacific Peptides, by Natural Peptides USD Million (2023-2028)
  • Table 250. Europe Peptides, by Country USD Million (2023-2028)
  • Table 251. Europe Peptides, by Type USD Million (2023-2028)
  • Table 252. Europe Peptides, by Application USD Million (2023-2028)
  • Table 253. Europe Peptides, by Natural Peptides USD Million (2023-2028)
  • Table 254. Germany Peptides, by Type USD Million (2023-2028)
  • Table 255. Germany Peptides, by Application USD Million (2023-2028)
  • Table 256. Germany Peptides, by Natural Peptides USD Million (2023-2028)
  • Table 257. France Peptides, by Type USD Million (2023-2028)
  • Table 258. France Peptides, by Application USD Million (2023-2028)
  • Table 259. France Peptides, by Natural Peptides USD Million (2023-2028)
  • Table 260. Italy Peptides, by Type USD Million (2023-2028)
  • Table 261. Italy Peptides, by Application USD Million (2023-2028)
  • Table 262. Italy Peptides, by Natural Peptides USD Million (2023-2028)
  • Table 263. United Kingdom Peptides, by Type USD Million (2023-2028)
  • Table 264. United Kingdom Peptides, by Application USD Million (2023-2028)
  • Table 265. United Kingdom Peptides, by Natural Peptides USD Million (2023-2028)
  • Table 266. Netherlands Peptides, by Type USD Million (2023-2028)
  • Table 267. Netherlands Peptides, by Application USD Million (2023-2028)
  • Table 268. Netherlands Peptides, by Natural Peptides USD Million (2023-2028)
  • Table 269. Rest of Europe Peptides, by Type USD Million (2023-2028)
  • Table 270. Rest of Europe Peptides, by Application USD Million (2023-2028)
  • Table 271. Rest of Europe Peptides, by Natural Peptides USD Million (2023-2028)
  • Table 272. MEA Peptides, by Country USD Million (2023-2028)
  • Table 273. MEA Peptides, by Type USD Million (2023-2028)
  • Table 274. MEA Peptides, by Application USD Million (2023-2028)
  • Table 275. MEA Peptides, by Natural Peptides USD Million (2023-2028)
  • Table 276. Middle East Peptides, by Type USD Million (2023-2028)
  • Table 277. Middle East Peptides, by Application USD Million (2023-2028)
  • Table 278. Middle East Peptides, by Natural Peptides USD Million (2023-2028)
  • Table 279. Africa Peptides, by Type USD Million (2023-2028)
  • Table 280. Africa Peptides, by Application USD Million (2023-2028)
  • Table 281. Africa Peptides, by Natural Peptides USD Million (2023-2028)
  • Table 282. North America Peptides, by Country USD Million (2023-2028)
  • Table 283. North America Peptides, by Type USD Million (2023-2028)
  • Table 284. North America Peptides, by Application USD Million (2023-2028)
  • Table 285. North America Peptides, by Natural Peptides USD Million (2023-2028)
  • Table 286. United States Peptides, by Type USD Million (2023-2028)
  • Table 287. United States Peptides, by Application USD Million (2023-2028)
  • Table 288. United States Peptides, by Natural Peptides USD Million (2023-2028)
  • Table 289. Canada Peptides, by Type USD Million (2023-2028)
  • Table 290. Canada Peptides, by Application USD Million (2023-2028)
  • Table 291. Canada Peptides, by Natural Peptides USD Million (2023-2028)
  • Table 292. Mexico Peptides, by Type USD Million (2023-2028)
  • Table 293. Mexico Peptides, by Application USD Million (2023-2028)
  • Table 294. Mexico Peptides, by Natural Peptides USD Million (2023-2028)
  • Table 295. Peptides Sales: by Type(K Units)
  • Table 296. Peptides Sales Custom (Standard , Quant , Cyclic Custom , Others) , by Region K Units (2023-2028)
  • Table 297. Peptides Sales Catalog (Neuroscience, Cardiovascular, Diabetes, Others) , by Region K Units (2023-2028)
  • Table 298. Peptides Sales: by Application(K Units)
  • Table 299. Peptides Sales Commercial , by Region K Units (2023-2028)
  • Table 300. Peptides Sales Academic Research , by Region K Units (2023-2028)
  • Table 301. Peptides Sales Therapeutics , by Region K Units (2023-2028)
  • Table 302. Peptides Sales: by Natural Peptides(K Units)
  • Table 303. Peptides Sales Insulin , by Region K Units (2023-2028)
  • Table 304. Peptides Sales Endorphins , by Region K Units (2023-2028)
  • Table 305. Peptides Sales Somatropin , by Region K Units (2023-2028)
  • Table 306. South America Peptides Sales, by Country K Units (2023-2028)
  • Table 307. South America Peptides Sales, by Type K Units (2023-2028)
  • Table 308. South America Peptides Sales, by Application K Units (2023-2028)
  • Table 309. South America Peptides Sales, by Natural Peptides K Units (2023-2028)
  • Table 310. Brazil Peptides Sales, by Type K Units (2023-2028)
  • Table 311. Brazil Peptides Sales, by Application K Units (2023-2028)
  • Table 312. Brazil Peptides Sales, by Natural Peptides K Units (2023-2028)
  • Table 313. Argentina Peptides Sales, by Type K Units (2023-2028)
  • Table 314. Argentina Peptides Sales, by Application K Units (2023-2028)
  • Table 315. Argentina Peptides Sales, by Natural Peptides K Units (2023-2028)
  • Table 316. Rest of South America Peptides Sales, by Type K Units (2023-2028)
  • Table 317. Rest of South America Peptides Sales, by Application K Units (2023-2028)
  • Table 318. Rest of South America Peptides Sales, by Natural Peptides K Units (2023-2028)
  • Table 319. Asia Pacific Peptides Sales, by Country K Units (2023-2028)
  • Table 320. Asia Pacific Peptides Sales, by Type K Units (2023-2028)
  • Table 321. Asia Pacific Peptides Sales, by Application K Units (2023-2028)
  • Table 322. Asia Pacific Peptides Sales, by Natural Peptides K Units (2023-2028)
  • Table 323. China Peptides Sales, by Type K Units (2023-2028)
  • Table 324. China Peptides Sales, by Application K Units (2023-2028)
  • Table 325. China Peptides Sales, by Natural Peptides K Units (2023-2028)
  • Table 326. Japan Peptides Sales, by Type K Units (2023-2028)
  • Table 327. Japan Peptides Sales, by Application K Units (2023-2028)
  • Table 328. Japan Peptides Sales, by Natural Peptides K Units (2023-2028)
  • Table 329. India Peptides Sales, by Type K Units (2023-2028)
  • Table 330. India Peptides Sales, by Application K Units (2023-2028)
  • Table 331. India Peptides Sales, by Natural Peptides K Units (2023-2028)
  • Table 332. South Korea Peptides Sales, by Type K Units (2023-2028)
  • Table 333. South Korea Peptides Sales, by Application K Units (2023-2028)
  • Table 334. South Korea Peptides Sales, by Natural Peptides K Units (2023-2028)
  • Table 335. Taiwan Peptides Sales, by Type K Units (2023-2028)
  • Table 336. Taiwan Peptides Sales, by Application K Units (2023-2028)
  • Table 337. Taiwan Peptides Sales, by Natural Peptides K Units (2023-2028)
  • Table 338. Australia Peptides Sales, by Type K Units (2023-2028)
  • Table 339. Australia Peptides Sales, by Application K Units (2023-2028)
  • Table 340. Australia Peptides Sales, by Natural Peptides K Units (2023-2028)
  • Table 341. Rest of Asia-Pacific Peptides Sales, by Type K Units (2023-2028)
  • Table 342. Rest of Asia-Pacific Peptides Sales, by Application K Units (2023-2028)
  • Table 343. Rest of Asia-Pacific Peptides Sales, by Natural Peptides K Units (2023-2028)
  • Table 344. Europe Peptides Sales, by Country K Units (2023-2028)
  • Table 345. Europe Peptides Sales, by Type K Units (2023-2028)
  • Table 346. Europe Peptides Sales, by Application K Units (2023-2028)
  • Table 347. Europe Peptides Sales, by Natural Peptides K Units (2023-2028)
  • Table 348. Germany Peptides Sales, by Type K Units (2023-2028)
  • Table 349. Germany Peptides Sales, by Application K Units (2023-2028)
  • Table 350. Germany Peptides Sales, by Natural Peptides K Units (2023-2028)
  • Table 351. France Peptides Sales, by Type K Units (2023-2028)
  • Table 352. France Peptides Sales, by Application K Units (2023-2028)
  • Table 353. France Peptides Sales, by Natural Peptides K Units (2023-2028)
  • Table 354. Italy Peptides Sales, by Type K Units (2023-2028)
  • Table 355. Italy Peptides Sales, by Application K Units (2023-2028)
  • Table 356. Italy Peptides Sales, by Natural Peptides K Units (2023-2028)
  • Table 357. United Kingdom Peptides Sales, by Type K Units (2023-2028)
  • Table 358. United Kingdom Peptides Sales, by Application K Units (2023-2028)
  • Table 359. United Kingdom Peptides Sales, by Natural Peptides K Units (2023-2028)
  • Table 360. Netherlands Peptides Sales, by Type K Units (2023-2028)
  • Table 361. Netherlands Peptides Sales, by Application K Units (2023-2028)
  • Table 362. Netherlands Peptides Sales, by Natural Peptides K Units (2023-2028)
  • Table 363. Rest of Europe Peptides Sales, by Type K Units (2023-2028)
  • Table 364. Rest of Europe Peptides Sales, by Application K Units (2023-2028)
  • Table 365. Rest of Europe Peptides Sales, by Natural Peptides K Units (2023-2028)
  • Table 366. MEA Peptides Sales, by Country K Units (2023-2028)
  • Table 367. MEA Peptides Sales, by Type K Units (2023-2028)
  • Table 368. MEA Peptides Sales, by Application K Units (2023-2028)
  • Table 369. MEA Peptides Sales, by Natural Peptides K Units (2023-2028)
  • Table 370. Middle East Peptides Sales, by Type K Units (2023-2028)
  • Table 371. Middle East Peptides Sales, by Application K Units (2023-2028)
  • Table 372. Middle East Peptides Sales, by Natural Peptides K Units (2023-2028)
  • Table 373. Africa Peptides Sales, by Type K Units (2023-2028)
  • Table 374. Africa Peptides Sales, by Application K Units (2023-2028)
  • Table 375. Africa Peptides Sales, by Natural Peptides K Units (2023-2028)
  • Table 376. North America Peptides Sales, by Country K Units (2023-2028)
  • Table 377. North America Peptides Sales, by Type K Units (2023-2028)
  • Table 378. North America Peptides Sales, by Application K Units (2023-2028)
  • Table 379. North America Peptides Sales, by Natural Peptides K Units (2023-2028)
  • Table 380. United States Peptides Sales, by Type K Units (2023-2028)
  • Table 381. United States Peptides Sales, by Application K Units (2023-2028)
  • Table 382. United States Peptides Sales, by Natural Peptides K Units (2023-2028)
  • Table 383. Canada Peptides Sales, by Type K Units (2023-2028)
  • Table 384. Canada Peptides Sales, by Application K Units (2023-2028)
  • Table 385. Canada Peptides Sales, by Natural Peptides K Units (2023-2028)
  • Table 386. Mexico Peptides Sales, by Type K Units (2023-2028)
  • Table 387. Mexico Peptides Sales, by Application K Units (2023-2028)
  • Table 388. Mexico Peptides Sales, by Natural Peptides K Units (2023-2028)
  • Table 389. Peptides: by Type(USD/Units)
  • Table 390. Research Programs/Design for This Report
  • Table 391. Key Data Information from Secondary Sources
  • Table 392. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Peptides: by Type USD Million (2017-2022)
  • Figure 5. Global Peptides: by Application USD Million (2017-2022)
  • Figure 6. Global Peptides: by Natural Peptides USD Million (2017-2022)
  • Figure 7. South America Peptides Share (%), by Country
  • Figure 8. Asia Pacific Peptides Share (%), by Country
  • Figure 9. Europe Peptides Share (%), by Country
  • Figure 10. MEA Peptides Share (%), by Country
  • Figure 11. North America Peptides Share (%), by Country
  • Figure 12. Global Peptides: by Type K Units (2017-2022)
  • Figure 13. Global Peptides: by Application K Units (2017-2022)
  • Figure 14. Global Peptides: by Natural Peptides K Units (2017-2022)
  • Figure 15. South America Peptides Share (%), by Country
  • Figure 16. Asia Pacific Peptides Share (%), by Country
  • Figure 17. Europe Peptides Share (%), by Country
  • Figure 18. MEA Peptides Share (%), by Country
  • Figure 19. North America Peptides Share (%), by Country
  • Figure 20. Global Peptides: by Type USD/Units (2017-2022)
  • Figure 21. Global Peptides share by Players 2022 (%)
  • Figure 22. Global Peptides share by Players (Top 3) 2022(%)
  • Figure 23. Global Peptides share by Players (Top 5) 2022(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Zealand Pharma A/S (Denmark) Revenue, Net Income and Gross profit
  • Figure 26. Zealand Pharma A/S (Denmark) Revenue: by Geography 2022
  • Figure 27. Tocris Bioscience (England) Revenue, Net Income and Gross profit
  • Figure 28. Tocris Bioscience (England) Revenue: by Geography 2022
  • Figure 29. AnaSpec, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. AnaSpec, Inc. (United States) Revenue: by Geography 2022
  • Figure 31. CSBio (United States) Revenue, Net Income and Gross profit
  • Figure 32. CSBio (United States) Revenue: by Geography 2022
  • Figure 33. GL Biochem (Shanghai) Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 34. GL Biochem (Shanghai) Ltd. (China) Revenue: by Geography 2022
  • Figure 35. CPC Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. CPC Scientific Inc. (United States) Revenue: by Geography 2022
  • Figure 37. Auspep Pty Ltd. (Australia) Revenue, Net Income and Gross profit
  • Figure 38. Auspep Pty Ltd. (Australia) Revenue: by Geography 2022
  • Figure 39. Peptides International Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Peptides International Inc. (United States) Revenue: by Geography 2022
  • Figure 41. Applied Biological Materials (ABM) Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 42. Applied Biological Materials (ABM) Inc. (Canada) Revenue: by Geography 2022
  • Figure 43. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 44. Thermo Fisher Scientific (United States) Revenue: by Geography 2022
  • Figure 45. PolyPeptide Group (Sweden) Revenue, Net Income and Gross profit
  • Figure 46. PolyPeptide Group (Sweden) Revenue: by Geography 2022
  • Figure 47. Global Peptides: by Type USD Million (2023-2028)
  • Figure 48. Global Peptides: by Application USD Million (2023-2028)
  • Figure 49. Global Peptides: by Natural Peptides USD Million (2023-2028)
  • Figure 50. South America Peptides Share (%), by Country
  • Figure 51. Asia Pacific Peptides Share (%), by Country
  • Figure 52. Europe Peptides Share (%), by Country
  • Figure 53. MEA Peptides Share (%), by Country
  • Figure 54. North America Peptides Share (%), by Country
  • Figure 55. Global Peptides: by Type K Units (2023-2028)
  • Figure 56. Global Peptides: by Application K Units (2023-2028)
  • Figure 57. Global Peptides: by Natural Peptides K Units (2023-2028)
  • Figure 58. South America Peptides Share (%), by Country
  • Figure 59. Asia Pacific Peptides Share (%), by Country
  • Figure 60. Europe Peptides Share (%), by Country
  • Figure 61. MEA Peptides Share (%), by Country
  • Figure 62. North America Peptides Share (%), by Country
  • Figure 63. Global Peptides: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Zealand Pharma A/S (Denmark)
  • Tocris Bioscience (England)
  • AnaSpec, Inc. (United States)
  • CSBio (United States)
  • GL Biochem (Shanghai) Ltd. (China)
  • CPC Scientific Inc. (United States)
  • Auspep Pty Ltd. (Australia)
  • Peptides International Inc. (United States)
  • Applied Biological Materials (ABM) Inc. (Canada)
  • Thermo Fisher Scientific (United States)
  • PolyPeptide Group (Sweden)
Additional players considered in the study are as follows:
Enzo Life Sciences, Inc. (United States) , JPT Peptide Technologies (Germany) , Abcam (Cambridgeshire) , Amgen Inc. (United States) , Aviva Systems Biology Corporation (United States)
Select User Access Type

Key Highlights of Report


Dec 2023 139 Pages 51 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Peptides Quantitative research analysis
Global Peptides Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Peptides market are Zealand Pharma A/S (Denmark), Tocris Bioscience (England), AnaSpec, Inc. (United States), CSBio (United States), GL Biochem (Shanghai) Ltd. (China), CPC Scientific Inc. (United States), Auspep Pty Ltd. (Australia), Peptides International Inc. (United States), Applied Biological Materials (ABM) Inc. (Canada), Thermo Fisher Scientific (United States) and PolyPeptide Group (Sweden), to name a few.
North America is dominating the Peptides Market.
"Stringent Regulations in Various Regions" is seen as one of the major challenges by many Industry Players of Peptides Market
The Peptides market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.
The Peptides market is expected to see a steady growth rate during projected year 2022 to 2028.

Know More About Global Peptides Report?

Have a Query? Click Here

Other Related Reports

DNA and Gene Chip Comprehensive Study by Type (Oligonucleotide Based Chips {Photolithographic Oligonucleotide Chips, Inkjet Print Technology Generated Oligonucleotide Chips}, CDNA Chips {Mechanical M...
$ 3750
Extremity Tissue Expander Comprehensive Study by Type (Upper extremities, Lower extremities), Application (Breast reconstruction, Scalp reconstruction, Oral and maxillofacial reconstruction, Paediatr...
$ 3650
Antibiotic Resistance Comprehensive Study by Disease (Complicated Urinary Tract Infection {cUTI}, Complicated Intra-Abdominal Infections {cIAI}, Blood Stream Infections {BSI}, Clostridium difficile i...
$ 3750
BioPharma Buffers Comprehensive Study by Type (Phosphates, Acetates, TRIS, Others), Application (Research Institution, Pharmaceutical Industry, Others), Distribution Channel (Online, Offline), Packag...
$ 3450
Protein Labeling Comprehensive Study by Type (Reagents, Kits, Services), Application (Cell-based Assays, Fluorescence Microscopy, Immunological Techniques, Mass Spectrometry, Protein Microarray), Pro...
$ 3750
Umbilical Cord Blood Banking Comprehensive Study by Application (Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders, Osteopetrosis, Others), Services (Sample Preservation, Analysis, Proc...
$ 3650